SCHEMBL20143969

SCHEMBL20143969

C=C/C=C(\C=C/C)COc1ccc(C(C#CC)CC(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 19/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19486963 0.92 FFAR1 (0.60) FFAR1
SCHEMBL20143970 0.90 FFAR1 (0.67) FFAR1
SCHEMBL20143976 0.86 FFAR1 (0.61) FFAR1
SCHEMBL19266651 0.86 FFAR1 (0.61) FFAR1
SCHEMBL21171673 0.78 FFAR1 (0.43) FFAR1
SCHEMBL21121099 0.78 FFAR1 (0.65) FFAR1
SCHEMBL22799991 0.78 FFAR1 (0.65) FFAR1
SCHEMBL21121101 0.78 FFAR1 (0.65) FFAR1
SCHEMBL21121023 0.76 FFAR1 (1.00) FFAR1
SCHEMBL21121024 0.76 FFAR1 (1.00) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969723-B2 3-(4-(benzyloxy)phenyl)hex-4-ynoic acid derivative, method of preparing same and pharmaceutical composition for preventing and treating metabolic disease including same as effective ingredient HYUNDAI PHARM CO., LTD (KR) 2018-05-15 US disclosed